LD-2 disclosure · 4th Quarter - Report

CROHN'S & COLITIS FOUNDATION

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 29, 2026Filing document ↗LDA record ↗

Expenses$40Kself-filed spend

Client

1 issue

Health Issues
H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies Reauthorization of ACA tax subsidies.
Lobbyistsms ERIN HENNESSEY MCKEON
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS) · Natl Institutes of Health (NIH)

LD-2 disclosure · 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 29, 2026Filing document ↗LDA record ↗

Expenses$40Kself-filed spend

1 issue

Health Issues
H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies Reauthorization of ACA tax subsidies.
Lobbyistsms ERIN HENNESSEY MCKEON
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS) · Natl Institutes of Health (NIH)